Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Might be a good first two weeks of Dec.
Over 10 cents by Jan 15th.
Santa's early present ….
Peter says "Blah, Blah, Blah …
and oh by the way we got the FDA approval …
and oh by the way we had another complete remission.
I think/hope the price goes UP, UP & AWAY UP.
At this point, I don't care what they do or why … just as long as the price continues to go UP & UP & UP & HIGHER UP.
JUST KEEP GOING UP & UP & UP.
Don't know who has been doing the recent buying. If it is institutions, that's great. If it's retail like us, that's good.
BUT, BUT, if it is just short covering before any potential "Good" news on Dec. 3rd & 4th … then one of two things will happen.
If "Good" news, then price goes up more and more shorts will cover.
BUT, if it is not "Good" news, expect the shorters to short more again to try to drive the price back down again … so in the absence of some really positive news, don't be shocked or surprised when the shorts continue to play their game.
"The only logical explanation on our current share price is short sale manipulation by large hedge funds to discourage retail investors to sell and they pick up our shares at these ridiculous prices."
That sounds about right, unfortunately I don't think they are done with their games. Won't be until news that is so good they have to back off, cover and go elsewhere.
Shorts down but still over 4.6 million shares.
I'M NOT SAYING A WORD - DON'T WANT TO JINX ANYTHING.
Can you tell me what the confirmations were? I thought that officers and directors were part of the offering at $0.20?
But in all reality, it is all just blah, blah, blah, until THE PRICE GOES WAY UP.
COME ON NOW - let's all (that is the half dozen of us left on this board) go WAY OUT on a limb …
Above $8 by July 4th 2020 ???????????????????????????????????????????????
HOPE SO !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Wonder who the two "unnamed" buyers for Sorrento Therapeutics that were rejected were that had the stock price double?
I think people are just bummed out about these recent developments, can't blame them.
We made it through margin call selling, next we will have tax loss selling (which will also suck).
We just need some great news.
Screw the shorters, hope they burn in hell, (sorry, I know that is mean).
I am pissed off, AT MYSELF. To be honest I kept buying more and more and more all the way down from the mid $5's to the low $4's, and I got no more to invest right now as there are other priorities in the present and on the horizon for me.
Wish I did have more money to invest at these low prices, but it is what it is.
I'm just holding and waiting … what else can I do?
Happy Thanksgiving to you and all.
still here and still holding on.
Took a shot and bought more this morning, actually, tripled my holdings at this low price.
We are fighting two rules which are keeping most mutual funds from investing along with us.
It's either, they need a minimum market cap of one billion, or they need a minimum stock price of $5.
And, I think the shorters know it and are trying hard to keep us below those.
I also don't understand why nobody from Marker … (like James Allison - who has the credentials and provenance to get through) … has not reached out to Alex Trebek who is still going through rounds of chemo.
Will this stock skyrocket UP in 2020 or 2030?
Yeah OK, maybe in 2020 … or 2021 … or ...
OH, just GREAT.
Is this stock going to …
make me rich before I turn 100 … in 37 years?
The science and time and hope, is about all we have left.
Tired of this nightmare, wake me up when it's over $20.
RIGHT ON CUE - "they" knew that Tuesday was the last day margin calls had to cover - so right at the end of the day, after everybody sold to cover their margin calls, it goes up in the last 20 minutes.
Thank You for your post, I hope you are correct.
Ok, so let me get this straight in my tiny brain.
Citadel and Susquehanna are the Major Shorters driving the price DOWN.
And at the same time, they are buying 191,000 calls (which I think means they are hoping the price is higher in the future so they can make money on the increase in future price) … BUT, by shorting the hell out of it, they are getting to buy their calls at a MUCH LOWER price than they ordinarily would have been able to.
SO, if the above is correct, will someone with a brain bigger than mine kindly explain to me … HOW THE HELL IS THAT LEGAL OR ALLOWED?
If that is not stock price manipulation, what the hell is?
I guess that is good news. I think everybody, retail guys like us and institutions are all waiting for one thing.
Just one bit of GREAT NEWS, not good news, not unambiguous news, not news open to interpretation … one bit of GREAT news which causes a run up to make the shorts decide to play elsewhere.
And then let MRKR's stock price be valued FAIRLY at what it deserves … WITHOUT outside interference or influence.
Right now, there are biotechs with market caps the same as MRKR's current, with NO trials started, everything in pre-clinical.
WTF, and that's without the positives of NO cytokine release syndrome, and without the positives of epitope spreading, and without the potential versus CAR-T.
So all I can do is repeat - WTF.
What I keep telling myself … and I don't know if I am just deceiving myself ... is … for every share of MRKR stock that is being sold, someone is buying it (and apparently believing in MRKR).
One thing that I have recently learned.
If I ever decide to unretire, I will not apply for a job as a phone psychic
as I definitely did not see any of this S#!T happening.
I can emphasize with your post. All I can say to you is … it may be best to do nothing for the next 7 days. See what happens tomorrow, see where we are at in a week.
Thank you for your answer and for all your insight. I'm not freaking out yet, but you know with my buy after buy all the way down, I'm getting really close to it right about now.
Tomorrow may be very bad, hoping for the dead cat bounce or at least a little of it.
Phantom, Please answer this for me. The IND phase 2 AML trial that is now "on hold", is that a new AML trial they wanted to start? or is that a current pipeline trial? Thank You
So, what you're saying is: THIS SUCKS
Phantom - Blu - science people - CRISPR article:
https://www.pennmedicine.org/news/news-releases/2019/november/results-first-us-trial-crispr-edited-immune-cells-cancer-patients-safety-of-approach
Opinions on CRISPR vs CAR-T vs MultiTAA?
"The approach in this study is closely related to CAR T cell therapy, which engineers patients’ own immune cells to fight their cancer, but it has some key differences. Just like CAR T, researchers begin by collecting a patient’s T cells through a blood draw. However, instead of arming these cells with a receptor like CD19, the team first uses CRISPR/Cas9 editing to remove three genes. The first two edits remove a T cell’s natural receptors to make sure the immune cells bind to the right part of the cancer cells. The third edit removes PD-1, a natural checkpoint that sometimes blocks T cells from doing their job. At that point, a lentivirus is used to insert an affinity-enhanced T cell receptor (TCR), which tells the edited T cells to target an antigen called NY-ESO-1.
Our use of CRISPR editing is geared toward improving the effectiveness of gene therapies, not editing a patient’s DNA."
P.S., this wasn't a public CRISPR company like Editas (partnered with JUNO on cancer) , it was a private company, TMUNITY.
WHY --- If, Published in Pharmacology Biochemistry and Behavior, Results Highlight Improvements in Multiple Motor, Sensory, and Autonomic Phenotypes Associated with Rett Syndrome --- is Good News , did the stock go DOWN?
OK, the last 16 months have been a ride. In June 2018, we were told the market cap, post merger would be 1 billion.
At that time 300 million seemed more reasonable, but now, here we are at less than 200 million, and that is after GOOD news on pancreatic cancer.
We got two months left in the year before tax loss selling season. HOPEFULLY before the end of the year, we get some info on TPIV legacy trials (after all, that's what most of us actually invested in before Marker came along), and also, hopefully, maybe, possibly, potentially, get some more good pancreatic news/update.
That would be nice.
SERIOUSLY, if shorts are NOT covering at these LOW prices … AND if all those who wanted to invest in the offering that was OVERSOLD are NOT buying at these LOW prices … AND if Baker Brothers, NEA, etc., (AFTER THE GOOD PANCREATIC NEWS) are not buying MORE at these LOW prices … then I don't know what is going on, so I might as well just stop thinking.
BELOW the offering price?, after the pancreatic news?, JUST CRAZY!.
WASHINGTON (AP) — President Donald Trump is nominating a cancer specialist from Texas to lead the Food and Drug Administration.
Dr. Stephen Hahn heads the medical staff at MD Anderson Cancer Center in Houston.
Good this lead to a slightly easier FDA process for breakthrough cancer therapies?
"I’m still amazed at the lack of market penetration for afrezza."
Yep, me too. I did good with MNKD, but thought I would do about 20 times better.